W. Brady

发表

Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.

P. Linsley, J. Bajorath, R. Peach, 1994, Immunity.

T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.

P. Linsley, C. Thompson, M. Gibson, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.

P. Linsley, A. Montag, J. Bluestone, 1992, Science.

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

P. Linsley, Lieping Chen, J. Ledbetter, 1992, Cell.

Cloning, Characterization, and Modeling of Mouse and Human Guanylate Kinases*

M. Black, M. Kokoris, M. Fitzgibbon, 1996, The Journal of Biological Chemistry.

Expression and function of B7 on human epidermal Langerhans cells.

P. Linsley, W. Brady, F. W. Symington, 1993, Journal of immunology.

CD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline Motif

L. Garrett-Sinha, L. Boise, J. Nair, 2015, The Journal of Immunology.

Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer

James R. Apgar, L. Mosyak, P. Moore, 2016, Antibodies.

Medullary thymic epithelium expresses a ligand for CTLA4 in situ and in vitro.

P. Linsley, S. Hosier, A. Farr, 1993, Journal of immunology.

Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeys

Y. Vugmeyster, A. Wahl, K. Mohler, 2011, Rheumatology.

Phorbol-12-myristate-13-acetate-treated human keratinocytes express B7-like molecules that serve a costimulatory role in T-cell activation.

P. Linsley, J. Simon, J. Ledbetter, 1993, The Journal of investigative dermatology.

CTLA-4 is a second receptor for the B cell activation antigen B7

P. Linsley, J. Ledbetter, N. Damle, 1991, The Journal of experimental medicine.

Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation

P. Linsley, A. Aruffo, J. Ledbetter, 1991, The Journal of experimental medicine.

Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation.

J. Orange, J. Derry, E. López-Granados, 2004, The Journal of clinical investigation.

Characterization of Human Inducible Costimulator Ligand Expression and Function1

E. Clark, J. Ledbetter, W. Brady, 2000, The Journal of Immunology.

Unique antigen recognition by a herpesvirus-specific TCR-gamma delta cell.

P. Linsley, J. Bluestone, R. Sciammas, 1994, Journal of immunology.

Co‐stimulation of murine CD4 T cell growth: cooperation between B7 and heat‐stable antigen

C. Janeway, W. Brady, Yang Liu, 1992, European journal of immunology.

Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1

P. Linsley, J. Bajorath, R. Peach, 1994, The Journal of experimental medicine.

Single-chain mono- and bispecific antibody derivatives with novel biological properties and antitumour activity from a COS cell transient expression system.

H. P. Fell, J Bajorath, M. Gayle, 1994, Therapeutic immunology.

CD20-Directed Small Modular Immunopharmaceutical, TRU-015, Depletes Normal and Malignant B Cells

P. Thompson, A. Wahl, J. Ledbetter, 2009, Clinical Cancer Research.

In vitro and in vivo anti-B cell lymphoma activities of TRU-016

A. Wahl, W. Brady, C. Cerveny, 2008 .

CTLA-4 is a second receptor for the B cell activation antigen B7

P. Linsley, J. Ledbetter, N. Damle, 1991, The Journal of experimental medicine.